000 01364 a2200373 4500
005 20250517212942.0
264 0 _c20180529
008 201805s 0 0 por d
022 _a2317-6385
024 7 _a10.1590/s1679-45082018ao4065
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChade, Milca Cezar
245 0 0 _aEvaluation of survivin immunoexpression in the differentiation of high- and low-grade breast ductal carcinoma in situ.
_h[electronic resource]
260 _bEinstein (Sao Paulo, Brazil)
_c2018
300 _aeAO4065 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aBreast Neoplasms
_xmetabolism
650 0 4 _aCarcinoma in Situ
_xmetabolism
650 0 4 _aCarcinoma, Ductal, Breast
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aInhibitor of Apoptosis Proteins
_xmetabolism
650 0 4 _aSurvivin
700 1 _aPiato, Sebastião
700 1 _aGalvão, Maria Antonieta Longo
700 1 _aAldrighi, José Mendes
700 1 _aNegrini, Rômulo
700 1 _aMateus, Evandro Falaci
700 1 _aMedeiros, Enio Martins
773 0 _tEinstein (Sao Paulo, Brazil)
_gvol. 16
_gno. 1
_gp. eAO4065
856 4 0 _uhttps://doi.org/10.1590/s1679-45082018ao4065
_zAvailable from publisher's website
999 _c28325876
_d28325876